Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance).
Hao XieJacqueline M LafkyBruce W MorlanPhilip J StellaShaker R DakhilGerald G GrossWilliam S LouiJoleen M HubbardSteven R AlbertsAxel GrotheyPublished in: Therapeutic advances in medical oncology (2020)
NCT00826540, URL:http://clinicaltrials.gov/ct2/show/NCT00826540.
Keyphrases
- metastatic colorectal cancer
- phase ii
- clinical trial
- open label
- computed tomography
- image quality
- vascular endothelial growth factor
- phase iii
- endothelial cells
- dual energy
- placebo controlled
- double blind
- contrast enhanced
- tertiary care
- randomized controlled trial
- positron emission tomography
- magnetic resonance
- smoking cessation